Company Filing History:

8 out of 20

Societe Civile Bioprojet

patents

2 out of 1,744

Institut National De La Sante Et De La Recherche Medicale

Societe Civile Bioproject

patents

5. 1 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2006

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7094773 - [object Object] (2006-08-22),

2. 6878723 - LTA4 hydrolase inhibitors (2005-04-12),

3. 6436973 - LTA4 hydrolase inhibitors (2002-08-20),

4. 6013829 - Process for the asymmetric synthesis of S-acyl derivatives of (2000-01-11),

5. 5670531 - Amino acid derivatives, the process for their preparation and their (1997-09-23),

6. 5646313 - Amino acid derivatives, processes for their preparation and their (1997-07-08),

7. 5612371 - Amino acid, derivatives, processes for their preparation and their (1997-03-18),

8. 5599951 - Amino acid derivatives, the process for their preparation and their (1997-02-04),

9. 5331008 - Thioester enantiomeric compounds and their therapeutic uses (1994-07-19),

10. 5296509 - Thioester enantiomeric compounds and their therapeutic uses (1994-03-22),

11. 5208255 - Thioester enantiomeric compounds and their therapeutic uses (1993-05-04),

12. 5136076 - Process for the preparation of amino acid-derived enatiomeric compounds (1992-08-04),

Title: Claude Gros: Innovator in Anti-Inflammatory Medicaments

Introduction

Claude Gros is a notable inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-inflammatory compounds. With a total of 12 patents to his name, Gros has established himself as a key figure in the pharmaceutical industry.

Latest Patents

Gros's latest patents focus on innovative compounds that exhibit anti-inflammatory activity. One of his inventions relates to compounds that inhibit leukotriene A (LTA), an enzyme responsible for the biosynthesis of leukotriene LTB, a major pro-inflammatory mediator. This invention not only addresses the therapeutic applications of these compounds but also outlines methods for their preparation. Another significant patent involves LTA4 hydrolase inhibitors, which are compounds that inhibit LTA hydrolase and have therapeutic, particularly anti-inflammatory, applications.

Career Highlights

Throughout his career, Claude Gros has worked with prominent organizations such as Société Civile Bioprojet and the Institut National de la Santé et de la Recherche Médicale. His work has been instrumental in advancing the understanding and treatment of inflammatory conditions through innovative medicinal compounds.

Collaborations

Gros has collaborated with notable individuals in his field, including Pierre Duhamel and Lucette Duhamel. These collaborations have contributed to the development of his groundbreaking inventions and patents.

Conclusion

Claude Gros is a distinguished inventor whose work in anti-inflammatory medicaments has had a significant impact on the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com